Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype

Next Previous
X
Search
Trial Profile

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2025

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Valiltramiprosate (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Biomarker; Registrational; Therapeutic Use
  • Acronyms APOLLOE4
  • Sponsors Alzheon

    • Most Recent Events

    • 07 Jan 2025 According to an Alzheon media release, topline data from this trial will be presented at Valiltramiprosate Symposium at Alzheimers Disease Parkinsons Disease (ADPD) ,Vienna in April 2025.
    • 18 Sep 2024 According to an Alzheon media release, company published the data of this trial in the scientific journal Alzheimers Dementia Translational Research & Clinical Interventions and is available at: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.12498
    • 01 Sep 2024 This trial has been completed in France (Global end date : 2024-07-29) according to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top